Genome-wide association study reveals a locus in ADARB2 for complete freedom from headache in Danish Blood Donors
-
Published:2024-05-27
Issue:1
Volume:7
Page:
-
ISSN:2399-3642
-
Container-title:Communications Biology
-
language:en
-
Short-container-title:Commun Biol
Author:
Olofsson Isa AmalieORCID, Kristjansson Ragnar P., Callesen Ida, Davidsson Olafur, Winsvold BendikORCID, Hjalgrim HenrikORCID, Ostrowski Sisse R.ORCID, Erikstrup ChristianORCID, Bruun Mie TopholmORCID, Pedersen Ole BirgerORCID, Burgdorf Kristoffer S., Banasik KarinaORCID, Sørensen Erik, Mikkelsen ChristinaORCID, Didriksen MariaORCID, Dinh Khoa ManhORCID, Mikkelsen Susan, , Winsvold Bendik, , Hjalgrim Henrik, Ostrowski Sisse R., Erikstrup Christian, Bruun Mie Topholm, Mikkelsen Christina, Didriksen Maria, Dinh Khoa Manh, Mikkelsen Susan, Pedersen Ole Birger, Burgdorf Kristoffer S., Brunak SørenORCID, Ullum Henrik, Chalmer Mona AmeriORCID, Olesen Jes, Kogelman Lisette J. A.ORCID, Hansen Thomas FolkmannORCID
Abstract
AbstractHeadache disorders are the most common disorders of the nervous system. The lifetime prevalence of headache disorders show that some individuals never experience headache. The etiology of complete freedom from headache is not known. To assess genetic variants associated with complete freedom from headache, we performed a genome-wide association study of individuals who have never experienced a headache. We included 63,992 individuals (2,998 individuals with complete freedom from headache and 60,994 controls) from the Danish Blood Donor Study Genomic Cohort. Participants were included in two rounds, from 2015 to 2018 and in 2020. We discovered a genome-wide significant association, with the lead variant rs7904615[G] in ADARB2 (EAF = 27%, OR = 1.20 [1.13–1.27], p = 3.92 × 10−9). The genomic locus was replicated in a non-overlapping cohort of 13,032 individuals (539 individuals with complete freedom from headache and 12,493 controls) from the Danish Blood Donor Study Genomic Cohort (p < 0.05, two-sided). Participants for the replication were included from 2015 to 2020. In conclusion, we show that complete freedom from headache has a genetic component, and we suggest that ADARB2 is involved in complete freedom from headache. The genomic locus was specific for complete freedom from headache and was not associated with any primary headache disorders.
Funder
Det Frie Forskningsråd Novo Nordisk Fonden
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Feigin, V. L. et al. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18, 459–480 (2019). 2. Steiner, T. J., Stovner, L. J., Jensen, R., Uluduz, D. & Katsarava, Z. Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019. J. Headache Pain. 21, 1–4 (2020). 3. Stovner, L. J., Zwart, J.-A., Hagen, K., Terwindt, G. M. & Pascual, J. Epidemiology of headache in Europe. Eur. J. Neurol. 13, 333–345 (2006). 4. Rasmussen, B. K., Jensen, R., Schroll, M. & Olesen, J. Epidemiology of headache in a general population-A prevalence study. J. Clin. Epidemiol. 44, 1147–1157 (1991). 5. Olofsson, I. A. et al. Prevalence and socio-demographic characteristics of persons who have never had a headache among healthy voluntary blood donors – a population-based study. Cephalalgia 40, 1055–1062 (2020).
|
|